InvestSMART

Xenitra Limited (ASX:XEN)

ALERT: Price-sensitive ASX Announcement for XEN
Current share price for XEN : $0.003 -0.001 (-25%)+
Announcement
Release
7 May 2026 9:21AM
Price at Release
$0.004
Full Release
download
Summary
Xenitra Limited announced it has successfully raised $1.25 million through a placement to institutional, professional, and sophisticated investors. The funds will be utilized for the expansion of OTC medicines, scaling the OPAL RWA token ecosystem, supporting working capital, and growth infrastructure. The placement includes issuing 416,666,667 fully paid ordinary shares at a price of $0.003 per share, along with an unquoted option for every two shares, exercisable at $0.004 and set to expire on April 2, 2028. Novus Capital Limited managed the placement, receiving a 6% fee and will be issued options and shares subject to shareholder approval.
Key Points
  • Xenitra Limited raised $1.25 million through a placement.
  • The placement includes the issue of 416,666,667 fully paid ordinary shares at $0.003 per share.
  • One attaching unquoted option for every two placement shares, exercisable at $0.004, expiring on April 2, 2028.
  • Funds will be used for OTC medicines expansion, scaling the OPAL RWA token ecosystem, working capital, and growth infrastructure.
  • Novus Capital Limited acted as the sole lead manager with a 6% fee.
  • 30,000,000 options and 15,000,000 shares will be issued to Novus, subject to shareholder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.